Stock Market Symbols
GIB (NYSE)
GIB.A (TSX)
www.cgi.com/newsroom
MONTRÉAL, Jan. 22,
2024 /PRNewswire/ - CGI (NYSE: GIB) (TSX: GIB.A), one
of the largest business and IT consulting companies in the world,
today announced a partnership with Körber aimed at enabling
pharmaceutical and life sciences companies to improve their
production processes by combining CGI's end-to-end services with
Körber's Werum PAS-X Manufacturing Execution System (MES) Suite.
The global partnership is designed to help clients increase
efficiency, accuracy, and safety in pharma products and enhance
decision-making through access to real-time data.
"CGI works side-by-side with clients to transform data into
actionable insights to drive smart, sustainable and resilient
operations," said Tim Hurlebaus
President, U.S. Commercial & State Government operations
and global executive sponsor for CGI's health and life sciences
business. "This includes combining the benefits of MES and Industry
5.0 to gather rich insights to enable operational excellence. Our
partnership with Körber complements our offerings portfolio,
enabling us to deliver innovative new services and solutions to
support the needs of our pharma and life sciences clients."
Körber's platform serves as a digital, real-time process
controller to shorten time-to-market, lower production costs and
enable a more patient-centric approach, improving outcomes and
leading to improved health. Compliant with Good Manufacturing
Practices, PAS-X MES presents a comprehensive view of data from
diverse integrated systems, enabling faster and more informed
decisions, which can be a critical advantage in an industry where
timing and accuracy are paramount.
"Our PAS-X Products and Service Suites facilitate seamless
digital transformation projects at our customers globally. By
combining forces with CGI's global presence, expertise and
complementary service portfolio in pharma and life sciences, we can
offer a unique and compelling value proposition. CGI is one of the
key partners to continue to expand our offering to our global
customers" says Jan-Henrik Dieckert,
COO Software, Körber Business Area Pharma.
Embedding robust IT and operational technology (OT) security,
CGI's business consulting and MES services expertise enables
faster, more seamless, and operationally integrated implementation
of the platform, including transformation through technical
integration, data migration, and organizational change management
and adoption.
"In our global client insights research, pharma and life
sciences executives said optimizing operations is their top
business priority. CGI serves as a trusted advisor to help them
achieve this priority through ROI-led digitization investments,"
said Maiken Lykke, Senior
Vice-President, CGI Denmark. "We work collaboratively with clients
to build solutions that tailor the right mix of services and
technologies for their needs. We are pleased to partner with Körber
to address the unique client challenges in this industry."
CGI delivers clinical and IT solutions for 11 of the top 20
global biotech and pharmaceutical companies, including helping
these organizations optimize their processes; launch new therapies
for cancer and rare diseases; and drive digital transformation
across their research & development, manufacturing and
commercial functions globally.
About CGI
Founded in 1976, CGI is among the largest independent IT and
business consulting services firms in the world. With 91,500
consultants and professionals across the globe, CGI delivers an
end-to-end portfolio of capabilities, from strategic IT and
business consulting to systems integration, managed IT and business
process services and intellectual property solutions. CGI works
with clients through a local relationship model complemented by a
global delivery network that helps clients digitally transform
their organizations and accelerate results. CGI Fiscal 2023
reported revenue is C$14.30 billion
and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB).
Learn more at cgi.com.
About Körber
We are Körber – an international technology group with more than
12,000 employees at over 100 locations worldwide and a common goal:
We turn entrepreneurial thinking into customer success and shape
the technological change. In the Business Areas Digital, Pharma,
Supply Chain, and Technologies, we offer products, solutions and
services that inspire. We act fast to customer needs, we execute
ideas seamlessly, and with our innovations we create added value
for our customers. In doing so, we are increasingly building on
ecosystems that solve the challenges of today and tomorrow. Körber
AG is the holding company of the Körber Group.
At the Körber Business Area Pharma we are delivering the
difference along the pharma value chain with our unique portfolio
of integrated solutions. With our software solutions we help drug
manufacturers to digitize their pharmaceutical, biotech and cell
& gene therapy production. The Werum PAS-X MES Suite is
recognized as the world's leading Manufacturing Execution System
for pharma, biotech and cell & gene. Our Werum PAS-X Savvy
Suite accelerates product commercialization with data analytics and
AI solutions and uncovers hidden business value. Learn more at
www.koerber-pharma.com.
View original
content:https://www.prnewswire.com/news-releases/cgi-and-korber-announce-global-partnership-to-enable-pharmaceutical-and-life-sciences-clients-to-improve-production-operations-302039977.html
SOURCE CGI Inc.